ENTO

Entero Therapeutics
ENTO

Overview Fund Activity

6 hedge funds and large institutions have $1.74M invested in Entero Therapeutics in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and closing their positions.

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Commonwealth Equity Services
1
Commonwealth Equity Services
Massachusetts
$55K
2
IWM
2
IHT Wealth Management
Illinois
$12K
3
UBS Group
3
UBS Group
Switzerland
$12K
4
SM
4
Sabby Management
Florida
$462K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
PA
1
Perceptive Advisors
New York
$877K 227,272 – –
SM
2
Sabby Management
Florida
$462K 119,693 +700 +0.6%
PCM
3
Parsons Capital Management
Rhode Island
$323K 83,818 – –
Commonwealth Equity Services
4
Commonwealth Equity Services
Massachusetts
$55K 14,247 +14,247 New
UBS Group
5
UBS Group
Switzerland
$12K 3,046 +2,429 +394%
IWM
6
IHT Wealth Management
Illinois
$12K 3,034 +3,034 New